Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Equity Ratio: 2017-2025

Historic Equity Ratio for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to 0.57.

  • Puma Biotechnology's Equity Ratio rose 76.42% to 0.57 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57, marking a year-over-year increase of 76.42%. This contributed to the annual value of 0.43 for FY2024, which is 86.28% up from last year.
  • Latest data reveals that Puma Biotechnology reported Equity Ratio of 0.57 as of Q3 2025, which was up 5.76% from 0.54 recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Equity Ratio peaked at 0.57 during Q3 2025, and registered a low of -0.05 during Q3 2021.
  • Over the past 3 years, Puma Biotechnology's median Equity Ratio value was 0.24 (recorded in 2024), while the average stood at 0.32.
  • As far as peak fluctuations go, Puma Biotechnology's Equity Ratio tumbled by 2,688.30% in 2021, and later soared by 1,001.41% in 2022.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Equity Ratio stood at -0.01 in 2021, then soared by 1,001.41% to 0.10 in 2022, then skyrocketed by 138.24% to 0.23 in 2023, then spiked by 86.28% to 0.43 in 2024, then surged by 76.42% to 0.57 in 2025.
  • Its Equity Ratio was 0.57 in Q3 2025, compared to 0.54 in Q2 2025 and 0.49 in Q1 2025.